TAPI-2 inhibits MMPs, enzymes that degrade extracellular matrix components, thus having potential therapeutic applications in cancer and chronic inflammatory diseases. It targets MMP.
Molecular Weight
415.53
Molecular Formula
C19H37N5O5
Targets
MMP: 20 μM
Form
Lyophilized powder
Purity
≥98%
Identity
Confirmed by NMR/HPLC/MS.
Applications
TAPI-2 is an MMP inhibitor used to study the inhibition of matrix metalloproteinases involved in tissue remodeling and cancer.
CD BioGlyco is a world-class biotechnology company with offices in many countries. Our products and services provide a viable option to what is otherwise available.
